Examination of the effect of electrolytic nano-platinum water intake on intestinal bacterial flora.

Examination of the effect of electrolytic nano-platinum water intake on intestinal bacterial flora. - Examination of the effect of electrolytic nano-platinum water intake on intestinal bacterial flora.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042267

Enrollment

Registered

2020-11-16

Start date

2020-11-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Drink 1000 ml (500 ml x 2 bottles) of electrolytic nano-platinum water daily. (Cannot be heated or used for cooking.) Drink 1000 ml (500 ml x 2 bottles) of placebo water daily. (Cannot be heated or us

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 20 to under 65 at the time of informed consent. 2. Men and Women 3. Those who defecate 2 to 5 times a week 4. Those who can drink 500 ml of water x 2 bottles a day 5. Those who can input electronic diary with smartphone / PC 6. Those who can obtain written consent

Exclusion criteria

Exclusion criteria: 1. Those who drink electrolyzed water (water generated by the generator) or hydrogen water on a daily basis 2. Currently being treated with drugs (abortive use is acceptable , but antibiotics and gastric acid secretion inhibitors cannot be used) 3. Those who have received antibiotics within the last 2 months 4. Those who have a current or history of serious illness 5. Those who have undergone surgical intestinal resection in the past 6. Those who take medicines, health foods, supplements, foods for specified health use, foods with functional claims that affect the intestinal function on a daily basis 7. Those who take yogurt and lactic acid bacteria drinks daily 8. Those who have a current or history of food allergies or drug allergies 9. Those who have excessive drinking habits 10. Those who have a smoking habit 11. Those who are currently pregnant or breastfeeding, or who wish to become pregnant during the test period 12. Those who are judged to be unsuitable for participation in this study by the investigators or the sub-investigators

Design outcomes

Primary

Measure	Time frame
Defecation survey (number of defecations, fecal properties by Bristol score, defecation volume, abdominal symptoms), stool short-chain fatty acid analysis, intestinal flora	—

Secondary

Measure	Time frame
Immune system markers (CD4, CD8), saliva sIgA measurement, endotoxin, serotonin	—

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026